Smokers and urinary genotoxins: Implications for selection of cohorts and modulation of endpoints in chemoprevention trials

Journal of Cellular Biochemistry

Volumn 63, Issue SUPPL. 25, 1996, Pages 92-98

  De Flora, Silvio ^a   Camoirano, Anna ^a   Bagnasco, Maria ^a   Bennicelli, Carlo ^a   Van Zandwijk, Nico ^b   Wigbout, Gea ^b   Qian, Geng Sun ^c   Zhu, Yuan Rong ^d   Kensler, Thomas W ^e  

^a UNIVERSITY OF GENOA   (Italy)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c SHANGHAI CANCER INSTITUTE   (China)

^d QIDONG LIVER CANCER INSTITUTE   (China)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

biomarkers; chemoprevention; DNA repair; mutagenicity; N acetylcysteine; oltipraz; urinary mutagens

Indexed keywords

ACETYLCYSTEINE; AFLATOXIN; OLTIPRAZ; ANTINEOPLASTIC AGENT; MUTAGENIC AGENT; PYRAZINE DERIVATIVE; TUMOR MARKER;

ADULT; ARTICLE; CANCER PREVENTION; CHINA; CIGARETTE SMOKING; CLINICAL TRIAL; DIAGNOSTIC VALUE; DNA REPAIR; DOSE TIME EFFECT RELATION; FEMALE; GENOTOXICITY; HUMAN; HUMAN CELL; HUMAN TISSUE; ITALY; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; PHASE 2 CLINICAL TRIAL; POPULATION RESEARCH; PRIORITY JOURNAL; URINARY EXCRETION; CHEMISTRY; CHEMOPROPHYLAXIS; COHORT ANALYSIS; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; MUTAGEN TESTING; SMOKING; URINE;

ANIMALIA; ESCHERICHIA COLI; HEPATITIS B VIRUS; SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

ACETYLCYSTEINE; ADULT; ANTICARCINOGENIC AGENTS; CHEMOPREVENTION; CHINA; CLINICAL TRIALS, PHASE II; COHORT STUDIES; DNA REPAIR; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTAGENICITY TESTS; MUTAGENS; NETHERLANDS; PYRAZINES; RESEARCH DESIGN; SMOKING; TUMOR MARKERS, BIOLOGICAL;

EID: 0030512302     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(1996)25+<92::AID-JCB13>3.0.CO;2-P     Document Type: Article

References (20)

1. Vainio H, Sorsa M, Falck K (1984): Bacterial urinary assay in monitoring exposure to mutagens and carcinogens. In Berlin A, Draper M, Hemminki K, Vainio H (eds): "Monitoring Human Exposure to Carcinogenic and Mutagenic Agents." IARC Scientific Publications No. 59-1CPS Joint Symposia No. 7, Lyon, France: International Agency for Research on Cancer, pp 247-258.
2. Rynard SM (1990): Urine mutagenicity assays. In Hulka DS, Wilcosky TC, Griffith JT (eds): "Biological Markers in Epidemiology." New York, Oxford: Oxford University Press, pp 56-77.
3. Yamasaki E, Ames BN (1977): Concentration of mutagens from urine by adsorption with the non-polar resin XAD-2: Cigarette smokers have mutagenic urine. Proc Natl Acad Sci U S A 74:3555-3559.
4. Hayatsu H, Hayatsu T (1993): Suppressing effect of Lactobacillus casei administration on the urinary mutagenicity arising from ingestion of fried ground beef in the human. Cancer Lett 73:173-179.
5. Maron DM, Ames BN (1983): Revised methods for the Salmonella mutagenicity test. Mutat Res 113:173-215.
6. De Flora S, Zanacchi P, Camoirano A, Bennicelli C, Badolati G (1984): Genotoxic activity and potency of 135 compounds in the Ames reversion test and in a bacterial DNA-repair test. Mutat Res 133:161-198.
7. Watanabe M, Ishidate M Jr, Nohmi T (1990): Sensitive method for the detection of mutagenic nitroarenes and aromatic amines: New derivatives of Salmonella typhimurium tester strains possessing elevated O-acetyl transferase levels. Mutat Res 234:337-348.
8. De Flora S, Balansky R, Gasparini L, Camoirano A (1995): Bacterial mutagenicity of cigarette smoke and its interaction with ethanol. Mutagenesis 10:47-52.
9. Hirvonen A, Nylund L, Kociba P, Husgafvel-Pursiainen K, Vainio H (1994): Modulation of urinary mutagenicity by genetically determined carcinogen metabolism in smokers. Carcinogenesis 15:813-815.
10. Lidbeck A, Övervik E, Rafter J, Nord CE, Gustafsson J-A (1992): Effect of Lactobacillus acidophilus supplements on mutagen excretion in faeces and urine in humans. Microbial Ecol Hlth Dis 5:59-67.
11. Polasa K, Raghuram TC, Krishna TP, Krishnaswamy K (1992): Effect of turmeric on urinary mutagens in smokers. Mutagenesis 7:107-109.
12. De Flora S, Cesarone CF, Balansky RM, Albini A, D'Agostini F, Bennicelli C, Bagnasco M, Camoirano A, Scatolini L, Rovida A, Izzotti A (1995): Chemopreventive properties and mechanisms of N-acetylcysteine. The experimental background. J Cell Biochem 22 (Suppl):33-41.
13. Kensler TW, Helzlsouer KJ (1995): Oltipraz: Clinical opportunities for cancer chemoprevention. J Cell Biochem 22 (Suppl):101-107.
14. Kelloff GJ, Crowell JA, Boone CW, Steele VE, Lubet RA, Greenwald P, Alberta DS, Covey JM, Doody LA, Knapp GG, Nayfield S, Parkinson DR, Prasad VK, Prorok PC, Sausville EA, Sigman CC (1994): Clinical development plans for cancer chemopreventive agents. J Cell Biochem 20 (Suppl):63-73, 205-218.
15. Lynch AM, Knize MG, Boobis AR, Gooderham NJ, Davies DS, Murray S (1992): Intra- and inter-individual variability in systemic exposure in humans to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline and 2-ammo-1-methyl-6-phenylimidazo[4,5-b]pyridine, carcinogens present in cooked beef. Cancer Res 52:6216-6223.
16. van Zandwijk N, Pastorino U, de Vries N, Dalesio O (1993): Euroscan: The European Organization for Research and Treatment of Cancer (EORTC) chemoprevention study in lung cancer. Lung Cancer 9:351-356.
17. Izzotti A, Rossi GA, Bagnasco M, De Flora S (1991): Benzo(a)pyrene diolepoxide-DNA adducts in alveolar macrophages of smokers. Carcinogenesis 12:1281-1285.
18. Qian G-S, Ross RK, Yu MC, Yuan J-M, Gao Y-T, Henderson BE, Wogan GN, Groopman JD (1994): A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prev 3:3-10.
19. De Flora S, Bennicelli C, Camoirano A, Izzotti A, Hietanen E, Bartsch H, Picciotto A, Millman I (1990): Metabolic activation of food hepatocarcinogens in hepatitis B virus-infected humans and animals. In Pariza MW, Aeschbacher H-U, Felton JS, Sato S (eds): "Mutagens and Carcinogens in the Diet." New York: Wiley-Liss, pp 167-172.
20. Izzotti A, Scatolini L, Lewtas J, Walsh D, De Flora S (1995): Enhanced formation of carcinogen-DNA adducts in the liver of woodchucks infected with hepatitis virus. Chem Biol Inter 97: 273-285.